BRAIN Biotech AG (LON:0RFI)
London flag London · Delayed Price · Currency is GBP · Price in EUR
2.290
+0.020 (0.88%)
At close: Feb 9, 2026

BRAIN Biotech AG Company Description

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom.

The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients.

The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry.

The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production.

The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021.

BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.

BRAIN Biotech AG
CountryGermany
Founded1993
IndustryBiological Products, Except Diagnostic Substances
Employees292
CEOAdriaan Moelker

Contact Details

Address:
Darmstädter Strasse 34-36
Zwingenberg, 64673
Germany
Phone49 62 51 9331 0
Websitebrain-biotech.com

Stock Details

Ticker Symbol0RFI
ExchangeLondon Stock Exchange
Fiscal YearOctober - September
Reporting CurrencyEUR
ISIN NumberDE0005203947
SIC Code2836

Key Executives

NamePosition
Adriaan MoelkerChairman of the Management Board and Chief Executive Officer
Ulrich PutschCo-Founder
Michael SchneidersChief Financial Officer and Member of Management Board
Dr. Ute DechertVice President of Human Resources and Processes
Dr. Jurgen EckConsultant
Dr. Martin LangerMD and Executive Vice President
Dr. Alexander PelzerVice President and Head of Research and Development - Zwingenberg
Robbert Michael HoekstraHead of Group Finance
Johan Jansen-StorbackaExecutive Vice President of BRAIN Biocatalysts enzyme products business